About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 740105, 15 pages
http://dx.doi.org/10.1155/2014/740105
Research Article

The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies

1Laboratory of Physiology and Animal Biochemistry, Department of Zoology and Invertebrate Ecology, Institute of Environmental Protection, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland
2Laboratory of Oxidative Stress, Center for Interdisciplinary Research, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland
3Laboratory of Separation and Spectroscopic Method Applications, Center for Interdisciplinary Research, The John Paul II Catholic University of Lublin, 102 Kraśnicka Avenue, 20-718 Lublin, Poland

Received 30 April 2013; Revised 22 October 2013; Accepted 28 October 2013; Published 28 January 2014

Academic Editor: Maha Zaki Rizk

Copyright © 2014 Agnieszka Ścibior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Z. Byczkowski and A. P. Kulkarni, “Oxidative stress and pro-oxidant biological effects of vanadium,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 235–264, John Wiley and Sons, New York, NY, USA, 1998.
  2. A. Ścibior, H. Zaporowska, and I. Niedźwiecka, “Lipid peroxidation in the liver of rats treated with V and/or Mg in drinking water,” Journal of Applied Toxicology, vol. 29, no. 7, pp. 619–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Ścibior, H. Zaporowska, and I. Niedźwiecka, “Lipid peroxidation in the kidney of rats treated with V and/or Mg in drinking water,” Journal of Applied Toxicology, vol. 30, no. 5, pp. 487–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ścibior, D. Gołębiowska, and I. Niedźwiecka, “Magnesium can protect against vanadium-induced lipid peroxidation in the hepatic tissue,” Oxidaive Medicine and Cellular Longevity, vol. 2013, Article ID 802734, 11 pages, 2013. View at Publisher · View at Google Scholar
  5. J. Donaldson and F. LaBella, “Prooxidant properties of vanadate in vitro on catecholamines and on lipid peroxidation by mouse and rat tissues,” Journal of Toxicology and Environmental Health, vol. 12, no. 1, pp. 119–126, 1983. View at Scopus
  6. M. H. Oster, J. M. Llobet, J. L. Domingo, J. B. German, and C. L. Keen, “Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects,” Toxicology, vol. 83, no. 1–3, pp. 115–130, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Soares, H. Martins, R. O. Duarte et al., “Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration,” Journal of Inorganic Biochemistry, vol. 101, no. 1, pp. 80–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Donaldson, R. Hemming, and F. LaBella, “Vanadium exposure enhances lipid peroxidation in the kidney of rats and mice,” Canadian Journal of Physiology and Pharmacology, vol. 63, no. 3, pp. 196–199, 1985. View at Scopus
  9. M. Carmignani, A. R. Volpe, E. Sabbioni, M. Felaco, and P. Boscolo, “Vanadium and the cardiovascular system: regulatory effects and toxicity,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., vol. 31, pp. 181–219, John Wiley and Sons, New York, NY, USA, 1998.
  10. K. De Cremer, M. Van Hulle, C. Chéry et al., “Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography,” Journal of Biological Inorganic Chemistry, vol. 7, no. 7-8, pp. 884–890, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Sitprija, K. Tungsanga, P. Tosukhowong et al., “Metabolic problems in northeastern Thailand: possible role of vanadium,” Mineral and Electrolyte Metabolism, vol. 19, no. 1, pp. 51–56, 1993. View at Scopus
  12. E. Dafnis and S. Sabatini, “Biochemistry and pathophysiology of vanadium,” Nephron, vol. 67, no. 2, pp. 133–143, 1994. View at Scopus
  13. P. Tosukhowong, K. Tungsanga, S. Eiam-Ong, and V. Sitprija, “Environmental distal renal tubular acidosis in Thailand: an enigma,” American Journal of Kidney Diseases, vol. 33, no. 6, pp. 1180–1186, 1999. View at Scopus
  14. A. S. Tracey, G. R. Willsky, and E. S. Takeuchi, Vanadium—Chemistry, Biochemistry, Pharmacology and Practical Applications, Taylor and Francis, Boca Raton, Fla, USA, 2007.
  15. S. M. Talbott and K. Hughes, The Health Professional’s Guide to Dietary Supplements, Lippincott Williams and Wilkins, 2007.
  16. V. Sitprija and S. Eiam-Ong, “Vanadium and metabolic problems,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 91–120, John Wiley and Sons, New York, NY, USA, 1998.
  17. Y. Teng, S. Ni, C. Zhang, J. Wang, X. Lin, and Y. Huang, “Environmental geochemistry and ecological risk of vanadium pollution in Panzhihua mining and smelting area, Sichuan, China,” Chinese Journal of Geochemistry, vol. 25, no. 4, pp. 379–385, 2006. View at Scopus
  18. Expert group on vitamins and minerals, Review of vanadium. EVM/00/04.REVISEDAUG, 2002.
  19. K. H. Thompson, M. Battell, and J. H. McNeill, “Toxicology of vanadium in mammals,” in Vanadium in the Environment Part II: Health Effects, J. O. Nriagu, Ed., pp. 21–38, John Wiley and Sons, New York, NY, USA, 1998.
  20. R. G. Fassett, S. K. Venuthurupalli, G. C. Gobe, J. S. Coombes, M. A. Cooper, and W. E. Hoy, “Biomarkers in chronic kidney disease: a review,” Kidney International, vol. 80, no. 8, pp. 806–821, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. D'Amico and C. Bazzi, “Urinary protein and enzyme excretion as markers of tubular damage,” Current Opinion in Nephrology and Hypertension, vol. 12, no. 6, pp. 639–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, “Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury,” American Journal of Physiology—Renal Physiology, vol. 290, no. 2, pp. F517–F529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Ścibior, A. Adamczyk, D. Gołebiowska, and I. Niedźwiecka, “Effect of 12-week vanadate and magnesium co-administration on chosen haematological parameters as well as on some indices of iron and copper metabolism and biomarkers of oxidative stress in rats,” Environmental Toxicology and Pharmacology, vol. 34, no. 2, pp. 235–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, and C. L. Keen, “Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation,” Molecular and Cellular Biochemistry, vol. 153, no. 1-2, pp. 233–240, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Azay, J. Brès, M. Krosniak et al., “Vanadium pharmacokinetics and oral bioavailability upon single-dose administration of vanadyl sulfate to rats,” Fundamental and Clinical Pharmacology, vol. 15, no. 5, pp. 313–324, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. World Health Organization, Vanadium Pentoxide and Other Inorganic Vanadium Compounds, WHO, Geneva, Switzerland, 2001.
  27. International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans, Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, vol. 86, Lyon, France, 2006.
  28. A. Ścibior and H. Zaporowska, “Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney,” Journal of Toxicology and Environmental Health A, vol. 70, no. 8, pp. 696–704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Barrio and S. B. Etcheverry, “Vanadium and bone development: putative signaling pathways,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 7, pp. 677–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Ścibior, H. Zaporowska, A. Wolińska, and J. Ostrowski, “Antioxidant enzyme activity and lipid peroxidation in the blood of rats co-treated with vanadium (V+5) and chromium (Cr+3),” Cell Biology and Toxicology, vol. 26, no. 6, pp. 509–526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Baxmann, M. S. Ahmed, N. C. Marques et al., “Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 348–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. D. Sarkar, G. Rajeshwari, and T. M. Shivaprakash, “Cystatin C—A novel marker of glomerular filtration: a review,” Indian Journal of Clinical Biochemistry, vol. 20, no. 1, pp. 139–144, 2005. View at Scopus
  33. G. H. Tesch, “Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective,” Nephrology, vol. 15, no. 6, pp. 609–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Warwas and A. Piwowar, “Moczowa cystatyna C jako biomarker uszkodzenia kanalików nerkowych,” Postępy Higieny i Medycyny Doświadczalnej, vol. 65, pp. 562–568, 2011.
  35. J. Westhuyzen, “Cystatin C: a promising marker and predictor of impaired renal function,” Annals of Clinical and Laboratory Science, vol. 36, no. 4, pp. 387–394, 2006. View at Scopus
  36. A. De La Torre, S. Granero, E. Mayayo, J. Corbella, and J. L. Domingo, “Effect of age on vanadium nephrotoxicity in rats,” Toxicology Letters, vol. 105, no. 1, pp. 75–82, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Cortizo, V. C. Salice, and S. B. Etcheverry, “Vanadium compounds: their action on alkaline phosphatase activity,” Biological Trace Element Research, vol. 41, no. 3, pp. 331–339, 1994. View at Scopus
  38. A. M. Evangelou, “Vanadium in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 249–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ścibior and H. Zaporowska, “Effects of combined vanadate and magnesium treatment on erythrocyte antioxidant defence system in rats,” Environmental Toxicology and Pharmacology, vol. 30, no. 2, pp. 153–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. X.-G. Yang, X.-D. Yang, L. Yuan, K. Wang, and D. C. Crans, “The permeability and cytotoxicity of insulin-mimetic vanadium compounds,” Pharmaceutical Research, vol. 21, no. 6, pp. 1026–1033, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Liu, H. Cui, X. Liu et al., “Dietary high vanadium causes oxidative damage-induced renal and hepatic toxicity in broilers,” Biological Trace Element Research, vol. 145, no. 2, pp. 189–200, 2012. View at Publisher · View at Google Scholar · View at Scopus